Renaissance Technologies
ARA

Renaissance Technologies’s American Renal Associates Holdings, Inc ARA Stock Holding History

Renaissance Technologies’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-824,675
Closed -$9.44M – 3910
2020
Q4 		$9.44M Sell
824,675
-293,000
-26% -$3.34M 0.01% 1211
2020
Q3 		$7.71M Buy
1,117,675
+27,800
+3% +$183K 0.01% 1310
2020
Q2 		$7.11M Buy
1,089,875
+30,600
+3% +$198K 0.01% 1417
2020
Q1 		$7M Buy
1,059,275
+22,575
+2% +$197K 0.01% 1373
2019
Q4 		$10.8M Buy
1,036,700
+91,725
+10% +$784K 0.01% 1400
2019
Q3 		$5.97M Buy
944,975
+306,015
+48% +$2.28M 0.01% 1691
2019
Q2 		$4.75M Buy
638,960
+177,100
+38% +$1.17M ﹤0.01% 1844
2019
Q1 		$2.84M Sell
461,860
-28,900
-6% -$335K ﹤0.01% 2131
2018
Q4 		$5.65M Buy
490,760
+32,960
+7% +$562K 0.01% 1639
2018
Q3 		$9.91M Buy
457,800
+110,300
+32% +$2.09M 0.01% 1365
2018
Q2 		$5.48M Buy
347,500
+183,000
+111% +$2.88M 0.01% 1730
2018
Q1 		$3.1M Buy
+164,500
New +$3.24M ﹤0.01% 2086

Renaissance Technologies's ARA Position: Q1 2021 in Review

Renaissance Technologies sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 824,675 shares — an estimated $9.44M sold.

Renaissance Technologies first reported a position in ARA in Q1 2018 and held it in 12 quarters. The position peaked at $10.8M in Q4 2019. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Renaissance Technologies reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Renaissance Technologies sold 824,675 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $9.44M.
  • Renaissance Technologies first reported a position in American Renal Associates Holdings, Inc in Q1 2018 and held it in 12 quarters.
  • Renaissance Technologies's American Renal Associates Holdings, Inc position peaked at $10.8M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.